| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |